Cargando…
Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles
In recent years, natural polysaccharides have been widely used in the preparation of drug delivery systems. In this paper, novel polysaccharide-based nanoparticles were prepared by layer-by-layer assembly technology using silica as a template. The layers of nanoparticles were constructed based on th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255217/ https://www.ncbi.nlm.nih.gov/pubmed/37299309 http://dx.doi.org/10.3390/polym15112510 |
_version_ | 1785056817390288896 |
---|---|
author | Chen, Xuelian Liu, Lijia Shen, Chen Liu, Fangyan Xu, Enyu Chen, Yin Jie, Wang |
author_facet | Chen, Xuelian Liu, Lijia Shen, Chen Liu, Fangyan Xu, Enyu Chen, Yin Jie, Wang |
author_sort | Chen, Xuelian |
collection | PubMed |
description | In recent years, natural polysaccharides have been widely used in the preparation of drug delivery systems. In this paper, novel polysaccharide-based nanoparticles were prepared by layer-by-layer assembly technology using silica as a template. The layers of nanoparticles were constructed based on the electrostatic interaction between a new pectin named NPGP and chitosan (CS). The targeting ability of nanoparticles was formed by grafting the RGD peptide, a tri-peptide motif containing arginine, glycine, and aspartic acid with high affinity to integrin receptors. The layer-by-layer assembly nanoparticles (RGD-(NPGP/CS)(3)NPGP) exhibited a high encapsulation efficiency (83.23 ± 6.12%), loading capacity (76.51 ± 1.24%), and pH-sensitive release property for doxorubicin. The RGD-(NPGP/CS)(3)NPGP nanoparticles showed better targeting to HCT-116 cells, the integrin αvβ3 high expression human colonic epithelial tumor cell line with higher uptake efficiency than MCF7 cells, the human breast carcinoma cell line with normal integrin expression. In vitro antitumor activity tests showed that the doxorubicin-loaded nanoparticles could effectively inhibit the proliferation of the HCT-116 cells. In conclusion, RGD-(NPGP/CS)(3)NPGP nanoparticles have potential as novel anticancer drug carriers because of their good targeting and drug-carrying activity. |
format | Online Article Text |
id | pubmed-10255217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102552172023-06-10 Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles Chen, Xuelian Liu, Lijia Shen, Chen Liu, Fangyan Xu, Enyu Chen, Yin Jie, Wang Polymers (Basel) Article In recent years, natural polysaccharides have been widely used in the preparation of drug delivery systems. In this paper, novel polysaccharide-based nanoparticles were prepared by layer-by-layer assembly technology using silica as a template. The layers of nanoparticles were constructed based on the electrostatic interaction between a new pectin named NPGP and chitosan (CS). The targeting ability of nanoparticles was formed by grafting the RGD peptide, a tri-peptide motif containing arginine, glycine, and aspartic acid with high affinity to integrin receptors. The layer-by-layer assembly nanoparticles (RGD-(NPGP/CS)(3)NPGP) exhibited a high encapsulation efficiency (83.23 ± 6.12%), loading capacity (76.51 ± 1.24%), and pH-sensitive release property for doxorubicin. The RGD-(NPGP/CS)(3)NPGP nanoparticles showed better targeting to HCT-116 cells, the integrin αvβ3 high expression human colonic epithelial tumor cell line with higher uptake efficiency than MCF7 cells, the human breast carcinoma cell line with normal integrin expression. In vitro antitumor activity tests showed that the doxorubicin-loaded nanoparticles could effectively inhibit the proliferation of the HCT-116 cells. In conclusion, RGD-(NPGP/CS)(3)NPGP nanoparticles have potential as novel anticancer drug carriers because of their good targeting and drug-carrying activity. MDPI 2023-05-30 /pmc/articles/PMC10255217/ /pubmed/37299309 http://dx.doi.org/10.3390/polym15112510 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Xuelian Liu, Lijia Shen, Chen Liu, Fangyan Xu, Enyu Chen, Yin Jie, Wang Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles |
title | Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles |
title_full | Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles |
title_fullStr | Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles |
title_full_unstemmed | Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles |
title_short | Preparation and Properties of Natural Polysaccharide-Based Drug Delivery Nanoparticles |
title_sort | preparation and properties of natural polysaccharide-based drug delivery nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255217/ https://www.ncbi.nlm.nih.gov/pubmed/37299309 http://dx.doi.org/10.3390/polym15112510 |
work_keys_str_mv | AT chenxuelian preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles AT liulijia preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles AT shenchen preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles AT liufangyan preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles AT xuenyu preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles AT chenyin preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles AT jiewang preparationandpropertiesofnaturalpolysaccharidebaseddrugdeliverynanoparticles |